Effect of TECAR Therapy on Pain, Balance, and Quality of Life in Elderly Men With Knee Osteoarthritis

NCT07633795 | Not Yet Recruiting DMC

• 1 other identifier: TECAR therapy on Arthritis
• Study Type: interventional
• Target: 80
• Locations: 0 countries
• Sites: N/A

Brief Summary

Evaluate the effect of TECAR therapy combined with traditional physiotherapy on pain, balance, and quality of life in elderly men with knee osteoarthritis .

Conditions

Knee Osteoarthritis

Outcome Measures

Primary Outcomes (1)

• Pain Intensity

  Visual Analog Scale will be used to assess pain intensity

  Baseline and after 8 weeks

Secondary Outcomes (2)

• Balance

  Baseline and after 8 weeks

• Health-Related Quality of Life

  Baseline and after 8 weeks

Study Arms (2)

Study group

ACTIVE COMPARATOR

40 elderly men with knee osteoarthritis who will receive TECAR therapy combined with a traditional physiotherapy program for 8 weeks

Device: True TECAR Therapy; Other: Traditional Physiotherapy

Control group

SHAM COMPARATOR

Will include 40 men participating in sham TECAR therapy plus the same traditional physiotherapy program for 8 weeks

Device: Sham TECAR; Other: Traditional Physiotherapy

Interventions

True TECAR Therapy DEVICE

20 minutes per session (10 mins capacitive mode, 10 mins resistive mode), 3 sessions per week for 8 weeks will be applied around the affected knee joint. Thermal delivery will be adjusted to a comfortable, non-painful warm sensation

Study group

Sham TECAR DEVICE

The device will be applied using identical electrode placement, application time, and interface screen indicators, but with the power output disabled so that no current or deep thermal energy is transferred to the tissues.

Control group

Traditional Physiotherapy OTHER

Standardized knee osteoarthritis rehabilitation including progressive quad/hamstring strengthening, hip abductor strengthening, range of motion exercises, and flexibility training

Control group; Study group

Eligibility Criteria

• Age: 65 Years - 75 Years
• Gender Eligibility Details: Only males are accepted
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)

You may qualify if:

• Clinical and radiographic diagnosis of mild and moderate bilateral or unilateral knee osteoarthritis meeting the American College of Rheumatology (ACR) criteria.
• Presence of chronic knee pain lasting for more than 6 months.
• Ability to ambulate independently with or without an assistive device.

You may not qualify if:

• Severe knee osteoarthritis (grade IV) requiring imminent surgical joint replacement.
• History of previous knee arthroplasty, internal fixation, or significant trauma to the affected lower extremity.
• Presence of pacemakers, metallic implants in the knee region, or severe. - peripheral vascular disease (absolute contraindications for TECAR therapy).
• Intra-articular injections (corticosteroids, platelet-rich plasma, or hyaluronic acid) into the knee within the past 3 months.
• Cognitive impairment or systemic inflammatory conditions (e.g., rheumatoid arthritis).

Sponsors & Collaborators

• Middle East University: lead

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

Osteoarthritis; Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases

Central Study Contacts

Saher Lotfy Elgayar, Ph.D

CONTACT

+201020429911; saherlotfy020@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor of Physiotherapy

Study Record Dates

• First Submitted: June 2, 2026
• First Posted: June 8, 2026
• Study Start: June 15, 2026
• Primary Completion (Estimated): October 15, 2026
• Study Completion (Estimated): October 18, 2026
• Last Updated: June 8, 2026

Record last verified: 2026-06

Data Sharing

• IPD Sharing: Will not share